Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics a randomized clinical trial
Anuoluwapo Osinusi, Eric G. Meissner, Yu Jin Lee, Dimitra Bon, Laura Heytens, Amy Nelson, Michael Sneller, Anita Kohli, Lisa Barrett, Michael Proschan, Eva Herrmann, Bhavana Shivakumar, Wenjuan Gu, Richard Kwan, Geb Teferi, Rohit Talwani, Rachel Silk, Colleen Kotb, Susan Wroblewski, Dawn FishbeinRobin Dewar, Helene Highbarger, Xiao Zhang, David Kleiner, Brad J. Wood, Jose Chavez, William T. Symonds, Mani Subramanian, John McHutchison, Michael A. Polis, Anthony S. Fauci, Henry Masur, Shyamasundaran Kottilil
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics a randomized clinical trial'. Together they form a unique fingerprint.